Beijing Science Sun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Beijing Science Sun Pharmaceutical Co Ltd cash flow reinvestment rate. Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting CN¥15.52 Million (capex CN¥15.52 Million ) from operating cash flow of CN¥28.68 Million. Explore Beijing Science Sun Pharmaceutical Co Lt (300485) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)
Cash flow reinvestment rate of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. Historical reinvestment intensity for Beijing Science Sun Pharmaceutical Co Ltd across 15 annual periods. Explore Beijing Science Sun Pharmaceutical Co Lt (300485) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Beijing Science Sun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2011–2025)
Beijing Science Sun Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Beijing Science Sun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Beijing Science Sun Pharmaceutical Co Lt generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.08x | CN¥191.73 Million | CN¥27.08 Million | CN¥100.28 Million | ▲ +442.3% |
| 2024 | 1.31x | CN¥177.53 Million | CN¥135.97 Million | CN¥101.13 Million | ▼ -80.1% |
| 2023 | 6.56x | CN¥139.18 Million | CN¥21.21 Million | CN¥52.91 Million | ▲ +857.5% |
| 2022 | 0.69x | CN¥75.68 Million | CN¥110.43 Million | CN¥43.28 Million | ▼ -82.6% |
| 2021 | 3.93x | CN¥720.68 Million | CN¥183.30 Million | CN¥45.91 Million | ▲ +190.7% |
| 2020 | 1.35x | CN¥356.74 Million | CN¥263.73 Million | CN¥117.84 Million | ▼ -24.7% |
| 2019 | 1.80x | CN¥310.12 Million | CN¥172.52 Million | CN¥111.42 Million | ▼ -74.0% |
| 2018 | 6.91x | CN¥1.01 Billion | CN¥146.52 Million | CN¥198.00 Million | ▲ +20.8% |
| 2017 | 5.72x | CN¥619.25 Million | CN¥108.21 Million | CN¥141.25 Million | ▲ +339.9% |
| 2016 | 1.30x | CN¥276.95 Million | CN¥212.89 Million | CN¥147.00 Million | ▼ -63.7% |
| 2015 | 3.58x | CN¥606.65 Million | CN¥169.36 Million | CN¥31.65 Million | ▲ +8382.4% |
| 2014 | 0.04x | CN¥9.05 Million | CN¥214.23 Million | CN¥9.05 Million | ▼ -57.2% |
| 2013 | 0.10x | CN¥19.42 Million | CN¥196.82 Million | CN¥19.42 Million | ▼ -81.4% |
| 2012 | 0.53x | CN¥80.76 Million | CN¥151.93 Million | CN¥80.76 Million | ▲ +50.1% |
| 2011 | 0.35x | CN¥27.29 Million | CN¥77.06 Million | CN¥27.29 Million | — |